Aquestive Therapeutics, Inc. Common Stock

AQSTNASDAQUSD
4.12 USD
0.18 (4.57%)AT CLOSE (11:59 AM EDT)
4.12
0.01 (0.12%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
4.12
0.01 (0.12%)
🔴Market: CLOSED

Shares of Aquestive Therapeutics, Inc. Common Stock (AQST) are trading at $4.13. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (202.4%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jul 17, 2026.

Open?$3.89
High?$4.16
Low?$3.81
Prev. Close?$3.94
Volume?2.4M
Avg. Volume?2.1M
VWAP?$4.03
Rel. Volume?1.14x
Bid / Ask
Bid?$3.51 × 100
Ask?$4.69 × 100
Spread?$1.18
Midpoint?$4.10
Valuation & Ratios
Market Cap?494.3M
Shares Out?125.5M
Float?100.0M
Float %?81.9%
P/E Ratio?N/A
P/B Ratio?-14.52
EPS?-$0.55
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Employees
147
Market Cap
494.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-07-25
Address
30 TECHNOLOGY DRIVE
WARREN, NJ 07059
Phone: 908-941-1900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
83
Short Sent.?
26
Piotroski F-Score?4/9Mixed
Altman Z-Score?-3.00Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.00%High
Short Interest?16.0M
Days to Cover?5.3
Free Float100.0M
Avg Daily Volume3.0M
Settlement Date2026-06-30
Financial Health
Current Ratio?4.10Strong
Quick Ratio?3.85Strong
Cash Ratio?3.49Strong
Debt/Equity?-1.14Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
S&P
97
-14.52CHEAP
P/S?
Peers
100
S&P
8
9.83HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-7.3CHEAP
EV/Sales?
Peers
100
S&P
16
8.40HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
97
202.4%STRONG
ROA?
S&P
3
-48.8%WEAK
Cash Flow & Enterprise
FCF?$-44317000
Enterprise Value?$422.4M
Fundamentals ratios updated end of day